Neeraj Sharma
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Neeraj Sharma has a total of 83 co-authors. Here are the top co-authors by number of shared publications:
- Peter Leif Bergsagel
Mayo Clinic Arizona
15 shared publications Cinthya Zepeda-Mendoza
13 shared publicationsJames B. Smadbeck
13 shared publicationsKathryn E. Pearce
12 shared publications- Nadine Abdallah
Division of Hematology, Mayo Clinic, Rochester, USA
12 shared publications Rhett P. Ketterling
12 shared publications
Latest Publications
- Open Access
- 5 October 2026
- Published by American Society of Hematology in Blood
Enriched Adaptive Immunity and Reduced Inflammatory Response in Plasma Cell Disorders of Self-Identified Black Patients
The immune tumor microenvironment (iTME) plays a crucial role in disease biology of plasma cell (PC) dyscrasias, but remains poorly characterized in self-identified Black individuals, a population at increased risk. Mass cytometry and scRNA-seq of 128 bone marrow aspirates revealed significant changes in immune cell composition across the disease spectrum, including shifts from naïve to effector T cells with declines in B cells, MAIT, pDCs, and increases in monocytes with disease progression. Self-identified Black patients had higher relative proportions of terminally differentiated T cells and lower monocytes in newly diagnosed and treated multiple myeloma (MM). ScRNA-seq revealed genes overexpressed in self-identified Black individuals were enriched for E2F targets and G2-M checkpoints, while reduced genes were enriched for TNF-α/NF-kB, interferon and inflammatory responses pathways. These findings were supported by genetic ancestry and validated in an independent dataset of 286 patients with MM from the MMRF Immune Atlas. Self-identified race and African genetic similarity are significantly associated with remodeling the MM iTME, with potential implications for disease biology and treatment response.
- 5 October 2026
- Published by American Society of Hematology in Blood
Open AccessEnriched Adaptive Immunity and Reduced Inflammatory Response in Plasma Cell Disorders of Self-Identified Black Patients
The immune tumor microenvironment (iTME) plays a crucial role in disease biology of plasma cell (PC) dyscrasias, but remains poorly characterized in self-identified Black individuals, a population at increased risk. Mass cytometry and scRNA-seq of 128 bone marrow aspirates revealed significant changes in immune cell composition across the disease spectrum, including shifts from naïve to effector T cells with declines in B cells, MAIT, pDCs, and increases in monocytes with disease progression. Self-identified Black patients had higher relative proportions of terminally differentiated T cells and lower monocytes in newly diagnosed and treated multiple myeloma (MM). ScRNA-seq revealed genes overexpressed in self-identified Black individuals were enriched for E2F targets and G2-M checkpoints, while reduced genes were enriched for TNF-α/NF-kB, interferon and inflammatory responses pathways. These findings were supported by genetic ancestry and validated in an independent dataset of 286 patients with MM from the MMRF Immune Atlas. Self-identified race and African genetic similarity are significantly associated with remodeling the MM iTME, with potential implications for disease biology and treatment response.
- Open Access
- 28 March 2026
- Published by Springer Nature in Blood Cancer Journal
- Vol. 16 (1)
A single next generation sequencing assay for detection of driver mutations, rearrangements and copy number abnormalities in plasma cell dyscrasias
- 28 March 2026
- Published by Springer Nature in Blood Cancer Journal
- Vol. 16 (1)
Open AccessA single next generation sequencing assay for detection of driver mutations, rearrangements and copy number abnormalities in plasma cell dyscrasias
- Open Access
- 29 October 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Data from The Prognostic Role of MYC Structural Variants Identified by NGS and FISH in Multiple Myeloma
Supplemental materials and methods and tables
- 29 October 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Data from The Prognostic Role of MYC Structural Variants Identified by NGS and FISH in Multiple Myeloma
Supplemental materials and methods and tables
- Open Access
- 29 October 2024
- Published by American Association for Cancer Research (AACR)
Supplemental Figure 3 from The Prognostic Role of MYC Structural Variants Identified by NGS and FISH in Multiple Myeloma
Supplemental Figure 3 shows schematic diagrams of 5 different MYC SVs and their interphase MYC FISH results
- 29 October 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Figure 3 from The Prognostic Role of MYC Structural Variants Identified by NGS and FISH in Multiple Myeloma
Supplemental Figure 3 shows schematic diagrams of 5 different MYC SVs and their interphase MYC FISH results
- Open Access
- 29 October 2024
- Published by American Association for Cancer Research (AACR)
Data from The Prognostic Role of MYC Structural Variants Identified by NGS and FISH in Multiple Myeloma
Purpose:Structural variants (SV) of the MYC gene region are common in multiple myeloma and influence disease progression. However, the prognostic significance of different MYC SVs in multiple myeloma has not been clearly established.Experimental Design:We conducted a retrospective study of multiple myeloma comparing MYC SV subtypes identified by next-generation sequencing (NGS) and FISH to MYC expression and disease survival using 140 cases from Mayo Clinic and 658 cases from the MMRF CoMMpass study.Results:MYC SVs were found in 41% of cases and were classified into nine subtypes. A correlation between the presence of a MYC SV and increased MYC expression was identified. Among the nine MYC subtypes, the non-immunoglobulin (non-Ig) insertion subtype was independently associated with improved outcomes, while the Ig insertion subtype, specifically involving the IgL gene partner, was independently associated with poorer outcomes compared with other MYC SV subtypes. Although the FISH methodology failed to detect approximately 70% of all MYC SVs, those detected by FISH were associated with elevated MYC gene expression and poor outcomes suggesting a different pathogenic role for FISH-detected MYC subtypes compared with other MYC subtypes.Conclusions:Understanding the impact of different MYC SVs on disease outcome is necessary for the reliable interpretation of MYC SVs in multiple myeloma. NGS approaches should be considered as a replacement technique for a more comprehensive evaluation of the multiple myeloma clone.
- 29 October 2024
- Published by American Association for Cancer Research (AACR)
Open AccessData from The Prognostic Role of MYC Structural Variants Identified by NGS and FISH in Multiple Myeloma
Purpose:Structural variants (SV) of the MYC gene region are common in multiple myeloma and influence disease progression. However, the prognostic significance of different MYC SVs in multiple myeloma has not been clearly established.Experimental Design:We conducted a retrospective study of multiple myeloma comparing MYC SV subtypes identified by next-generation sequencing (NGS) and FISH to MYC expression and disease survival using 140 cases from Mayo Clinic and 658 cases from the MMRF CoMMpass study.Results:MYC SVs were found in 41% of cases and were classified into nine subtypes. A correlation between the presence of a MYC SV and increased MYC expression was identified. Among the nine MYC subtypes, the non-immunoglobulin (non-Ig) insertion subtype was independently associated with improved outcomes, while the Ig insertion subtype, specifically involving the IgL gene partner, was independently associated with poorer outcomes compared with other MYC SV subtypes. Although the FISH methodology failed to detect approximately 70% of all MYC SVs, those detected by FISH were associated with elevated MYC gene expression and poor outcomes suggesting a different pathogenic role for FISH-detected MYC subtypes compared with other MYC subtypes.Conclusions:Understanding the impact of different MYC SVs on disease outcome is necessary for the reliable interpretation of MYC SVs in multiple myeloma. NGS approaches should be considered as a replacement technique for a more comprehensive evaluation of the multiple myeloma clone.
- Open Access
- 29 October 2024
- Published by American Association for Cancer Research (AACR)
Supplemental Figure 5 from The Prognostic Role of MYC Structural Variants Identified by NGS and FISH in Multiple Myeloma
Supplemental Figure 5 shows in influence of any MYC SV on OS and PFS in either the hyperdiploid or non-hyperdiploid groups of the CoMMpass cohort
- 29 October 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Figure 5 from The Prognostic Role of MYC Structural Variants Identified by NGS and FISH in Multiple Myeloma
Supplemental Figure 5 shows in influence of any MYC SV on OS and PFS in either the hyperdiploid or non-hyperdiploid groups of the CoMMpass cohort
- Open Access
- 29 October 2024
- Published by American Association for Cancer Research (AACR)
Supplemental Figure 2 from The Prognostic Role of MYC Structural Variants Identified by NGS and FISH in Multiple Myeloma
Supplemental Figure 2 shows Circos and Bubble plots indicating various MYC partners genes
- 29 October 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Figure 2 from The Prognostic Role of MYC Structural Variants Identified by NGS and FISH in Multiple Myeloma
Supplemental Figure 2 shows Circos and Bubble plots indicating various MYC partners genes
- Open Access
- 29 October 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 1 from The Prognostic Role of MYC Structural Variants Identified by NGS and FISH in Multiple Myeloma
Supplemental Figure 1 shows diagrams of the predicted genomic architecture of various MYC SVs
- 29 October 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 1 from The Prognostic Role of MYC Structural Variants Identified by NGS and FISH in Multiple Myeloma
Supplemental Figure 1 shows diagrams of the predicted genomic architecture of various MYC SVs
- Open Access
- 29 October 2024
- Published by American Association for Cancer Research (AACR)
Supplemental Figure 8 from The Prognostic Role of MYC Structural Variants Identified by NGS and FISH in Multiple Myeloma
Supplemental Figure 8 shows the distribution of MYC SVs in hyperdiploid and non-hyperdiploid groups
- 29 October 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Figure 8 from The Prognostic Role of MYC Structural Variants Identified by NGS and FISH in Multiple Myeloma
Supplemental Figure 8 shows the distribution of MYC SVs in hyperdiploid and non-hyperdiploid groups
- Open Access
- 29 October 2024
- Published by American Association for Cancer Research (AACR)
Supplemental Figure 7 from The Prognostic Role of MYC Structural Variants Identified by NGS and FISH in Multiple Myeloma
Supplemental Figure 7 shows the influence of various MYC SVs on OS and PFS of the CoMMpass cohort
- 29 October 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Figure 7 from The Prognostic Role of MYC Structural Variants Identified by NGS and FISH in Multiple Myeloma
Supplemental Figure 7 shows the influence of various MYC SVs on OS and PFS of the CoMMpass cohort